Pharmaceutical formulations are provided which are in the form of capsules or tablets for oral use and which include dapagliflozin propylene glycol hydrate is: Formula (Ia) or Formula (Ib) and a pharmaceutical acceptable carrier therefore, which formulation is designed for immediate release. The formulations are used for the treatment of diabetes and related diseases.